Evidence map›Paper›PMID 36602797›Full record

ArticleJAMA network open2023

Analysis of a Sabin-Strain Inactivated Poliovirus Vaccine Response to a Circulating Type 2 Vaccine-Derived Poliovirus Event in Sichuan Province, China 2019-2021.

Hong Yang, Qi Qi, Yong Zhang, Ning Wen, Lei Cao, Yu Liu, Chunxiang Fan, Dongmei Yan, Xiaoping Zhu, Lixin Hao and 22 more

Open access · goldAbstract read
In one paragraph

Article in JAMA network open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Vaccine Derived Poliovirus (VDPV).Le infezioni in medicina · 2023
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 4 institutions in 1 country.

Hong YangNational Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
Qi QiSichuan Provincial Center for Disease Control and Prevention, Chengdu, China.
Yong ZhangInstitute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Ning WenNational Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
Lei CaoNational Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
Yu LiuSichuan Provincial Center for Disease Control and Prevention, Chengdu, China.
Chunxiang FanNational Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
Dongmei YanInstitute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Xiaoping ZhuSichuan Provincial Center for Disease Control and Prevention, Chengdu, China.
Lixin HaoNational Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
Shuangli ZhuInstitute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Qianli MaSichuan Provincial Center for Disease Control and Prevention, Chengdu, China.
Jiajie LiuSichuan Provincial Center for Disease Control and Prevention, Chengdu, China.
Chao MaNational Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
Lei NanLiangshan Prefectural Center for Disease Control and Prevention, Liangshan, China.
Yong ChenLeibo County Center for Disease Control and Prevention, Liangshan, China.
Xiaozhen MaSichuan Provincial Center for Disease Control and Prevention, Chengdu, China.
Na ChenSichuan Provincial Center for Disease Control and Prevention, Chengdu, China.
Kun DengLiangshan Prefectural Center for Disease Control and Prevention, Liangshan, China.
Ge ShaoChinese Field Epidemiology Training Program, Beijing, China.
Xianxiang DingChinese Field Epidemiology Training Program, Beijing, China.
Zhijie AnNational Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
Lance E RodewaldNational Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
Xiaolei LiInstitute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Dongyan WangInstitute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Hui ZhuInstitute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Huaqing WangNational Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
Zijian FengChinese Center for Disease Control and Prevention, Beijing, China.
Wenbo XuInstitute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Jiushun ZhouSichuan Provincial Center for Disease Control and Prevention, Chengdu, China.
Zundong YinNational Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
China cVDPV2 Response Experts Group
Chinese Center For Disease Control and Prevention · CNSichuan Center for Disease Control and Prevention · CNNational Institute for Viral Disease Control and Prevention · CNNational Earthquake Response Support Service · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: The Sabin-strain inactivated poliovirus vaccine (IPV) may be a tool for polio outbreak response in certain situations. Objective: To investigate the response to a type 2 vaccine-derived poliovirus (VDPV2) outbreak. Design, Setting, and Participants: This case series was conducted in China after a VDPV2 was detected in stool specimens from a child with acute flaccid paralysis (AFP) in Sichuan Province in 2019, 3 years after the global withdrawal of live, attenuated type 2 oral poliovirus vaccine (OPV). Investigation followed National Health Commission and World Health Organization guidance and included searching hospitals for unreported AFP cases; testing stool specimens from the child, his contacts, and local children; enhanced environmental surveillance for VDPV2s in wastewater; and measuring vaccination coverage. Sabin-strain IPV campaigns were conducted in a wide geographic area. Main Outcomes and Measures: Any VDPV2 detection after completion of the supplementary immunization activities. Results: A 28-nucleotide-change VDPV2 was isolated from a young boy. Three VDPV2s were detected in healthy children; 2 were contacts of the original child, and none had paralysis. A search of 31 million hospital records found 10 unreported AFP cases; none were polio. No type 2 polioviruses were found in wastewater. Prior to the event, polio vaccine coverage was 65% among children younger than 5 years. Sabin-strain IPV campaigns reached more than 97% of targeted children, administering 1.4 million doses. No transmission source was identified. More than 1 year of enhanced poliovirus environmental and AFP surveillance detected no additional VDPVs. Conclusions and Relevance: These findings suggest that the circulating VPDV2 outbreak in 2019 was associated with low vaccine coverage. An investigation discovered 3 infected but otherwise healthy children and no evidence of the virus in wastewater. Following Sabin-strain IPV-only campaigns expanding from county to prefecture, the poliovirus was not detected, and the outbreak response was considered by an expert panel and the World Health Organization to have been successful. This success suggests that the Sabin-strain IPV may be a useful tool for responding to circulating VDPV2 outbreaks when high-quality supplementary immunization activities can be conducted and carefully monitored in settings with good sanitation.

Indexed as

PoliomyelitisPoliovirusalpha-FetoproteinsChildChinaHumansMalePoliovirus Vaccine, InactivatedWastewateralpha-FetoproteinsPoliovirus Vaccine, InactivatedWastewater

Identifiers

PMID36602797
PMCPMC9856606
OpenAlexW4313545405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.